Statistical Analysis on Determinant Factors Associated with Time to Death of HIV/TB Co-Infected Patients Under HAART at Debre Tabor Referral Hospital: An Application of Accelerated Failure Time-Shared Frailty Models

References

• World Health Organization. Tuberculosis Report 2019. World Health Organization; 2019.
   Google Scholar
• Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009–1021. doi:10.1001/archinte.163.9.1009
   PubMed Web of Science ®Google Scholar
• Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300(4):423–430.
   PubMed Web of Science ®Google Scholar
• Sonnenberg P, Glynn J, Fielding K, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005;191(2):150–158. doi:10.1086/426827
   PubMed Web of Science ®Google Scholar
• Getahun H, Gunneberg C, Granich R, et al. HIV infection—associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50(Supplement_3):S201–S207. doi:10.1086/651492
   Web of Science ®Google Scholar
• World Health Organization. Strategic Framework to Decrease the Burden of TB/HIV. Geneva: World Health Organization; 2002.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 2019, in Global Tuberculosis Report 2019. 2019.
   Google Scholar
• Kassu A, Mengistu G, Ayele B, et al. Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus-infected and-uninfected adults at a teaching hospital, northwest Ethiopia. J Microbiol Immunol Infect. 2007;40(2):116.
   Google Scholar
• Demissie M, Lindtjørn B, Tegbaru B. Human immunodeficiency virus (HIV) infection in tuberculosis patients in Addis Ababa. Ethiop J Health Dev. 2000;14(3). doi:10.4314/ejhd.v14i3.9900
   Google Scholar
• Nachega JB, Uthman OA, Ho Y-S, et al. Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol. 2012;41(6):1829–1846. doi:10.1093/ije/dys189
   Web of Science ®Google Scholar
• Nglazi MD, Bekker L-G, Wood R, et al. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study. BMC Infect Dis. 2015;15(1):536. doi:10.1186/s12879-015-1275-3
   Web of Science ®Google Scholar
• Wondimeneh Y, Muluye D, Belyhun Y. Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes. 2012;5(1):331. doi:10.1186/1756-0500-5-331
   Google Scholar
• Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis: clinical update. Clin Infect Dis. 2010;50(10):1377–1386. doi:10.1086/652147
   Web of Science ®Google Scholar
• Sterling TR, Pham PA, Chaisson RE. HIV infection—related tuberculosis: clinical manifestations and treatment. Clin Infect Dis. 2010;50(Supplement_3):S223–S230. doi:10.1086/651495
   Web of Science ®Google Scholar
• Reda AA, Biadgilign S, Deribew A, et al. Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a Retrospective Longitudinal Study. PLoS One. 2013;8(4):e58595. doi:10.1371/journal.pone.0058595
   PubMed Web of Science ®Google Scholar
• Hailu R, Eshetu W. Survival of HIV-TB co-infected adult patients under ART in Ambo referral hospital, Ethiopia. Ethiop J Health Dev. 2013;27(2):88–93.
   Web of Science ®Google Scholar
• Gezie LD. Predictors of CD4 count over time among HIV patients initiated ART in FelegeHiwot Referral Hospital, Northwest Ethiopia: multilevel analysis. BMC Res Notes. 2016;9(1):1–9. doi:10.1186/s13104-016-2182-4
   Google Scholar
• Mageda K, Leyna GH, Mmbaga EJ. High initial HIV/AIDS-Related mortality and-its predictors among patients on antiretroviral therapy in the Kagera region of Tanzania: a five-year retrospective cohort study. AIDS Res Treat. 2012;2012:1–7. doi:10.1155/2012/843598
   Google Scholar
• Nansera D, Bajunirwe F, Elyanu P, et al. Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda. Int J Tuberc Lung Dis. 2012;16(10):1371–1376. doi:10.5588/ijtld.11.0589
   Web of Science ®Google Scholar
• Seyoum D, Degryse J-M, Kifle Y, et al. Risk factors for mortality among adult HIV/AIDS patients following antiretroviral therapy in Southwestern Ethiopia: an assessment through survival models. Int J Environ Res Public Health. 2017;14(3):296. doi:10.3390/ijerph14030296
   PubMed Web of Science ®Google Scholar
• Taha M, Deribew A, Tessema F, et al. Risk factors of active tuberculosis in people living with HIV/AIDS in southwest Ethiopia: a Case Control Study. Ethiop J Health Sci. 2011;21(2):131–140. doi:10.4314/ejhs.v21i2.69053
   PubMedGoogle Scholar
• Temesgen A, Gurmesa A, Getchew Y. Joint modeling of longitudinal CD4 count and time-to-death of HIV/TB co-infected patients: a case of Jimma University Specialized Hospital. Ann Data Sci. 2018;5(4):659–678. doi:10.1007/s40745-018-0157-0
   Google Scholar
• Sinshaw Y, Alemu S, Fekadu A, et al. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an Institution Based Cross-Sectional Study. BMC Infect Dis. 2017;17(1):132. doi:10.1186/s12879-017-2238-7
   PubMed Web of Science ®Google Scholar
• Hosmer DW Jr, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time-To-Event Data. Vol. 618. John Wiley & Sons; 2011.
   Google Scholar
• Cox DR. Regression models and life‐tables. J R Stat Soc Series B Stat Methodol. 1972;34(2):187–202.
   Web of Science ®Google Scholar
• Lambert P, Collett D, Kimber A, et al. Parametric accelerated failure time models with random effects and an application to kidney transplant survival. Stat Med. 2004;23(20):3177–3192. doi:10.1002/sim.1876
   PubMed Web of Science ®Google Scholar
• Seid A, Getie M, Birlie B, Getachew Y. Joint modeling of longitudinal CD4 cell counts and time-to-default from HAART treatment: a comparison of separate and joint models. Electron J Appl Stat Anal. 2014;7(2):292–314.
   Google Scholar
• Adams M, Luguterah A. Longitudinal analysis of change in CD4+ cell counts of HIV-1 patients on antiretroviral therapy (ART) in the Builsa district hospital. Eur Sci J. 2013;9(33).
   Google Scholar
• Seyoum A, Zewotir T, Zewotir T. Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North–West Ethiopia (Amhara region). AIDS Res Ther. 2016;13(1):36. doi:10.1186/s12981-016-0119-6
   Web of Science ®Google Scholar
• Tarekegn S. The Effect of HAART on Incidence of Tuberculosis Among HIV Infected Patients in Hawassa University Referral Hospital. Addis Ababa: Addis Abba University; 2011.
   Google Scholar
• Mashimbye L. Tuberculosis (TB) Treatment Outcomes in Adult TB Patients Attending a Rural HIV Clinic in South Africa (Bushbuckridge). 2009.
   Google Scholar